These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22920717)

  • 21. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of beta-blockers in chronic congestive heart failure.
    Mahanonda N; Samranthin M; Panyarachun S
    J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
    Bruguera Cortada J; Varela A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart rate in coronary syndromes and heart failure.
    Orso F; Baldasseroni S; Maggioni AP
    Prog Cardiovasc Dis; 2009; 52(1):38-45. PubMed ID: 19615492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
    Haas SJ; Vos T; Gilbert RE; Krum H
    Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF.
    Mentz RJ; Fiuzat M; Wojdyla DM; Chiswell K; Gheorghiade M; Fonarow GC; O'Connor CM
    Eur J Heart Fail; 2012 Apr; 14(4):395-403. PubMed ID: 22302663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D; Goode KM; Cleland JG; Clark AL
    Heart; 2011 Dec; 97(23):1961-6. PubMed ID: 21917660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-based analysis of class effect of β blockers in heart failure.
    Lazarus DL; Jackevicius CA; Behlouli H; Johansen H; Pilote L
    Am J Cardiol; 2011 Apr; 107(8):1196-202. PubMed ID: 21349489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
    J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
    Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
    Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
    J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of heart rate and ivabradine in acute heart failure.
    Sciatti E; Vizzardi E; Bonadei I; Dallapellegrina L; Carubelli V
    Monaldi Arch Chest Dis; 2019 Oct; 89(3):. PubMed ID: 31594282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cutoff point for peak oxygen consumption in the prognosis of heart failure patients with β-blocker therapy.
    Guimaraes GV; d'Avila VM; Silva MS; Ferreira SA; Ciolac EG; Carvalho VO; Bocchi EA
    Int J Cardiol; 2010 Nov; 145(1):75-7. PubMed ID: 19477026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.